Theranostics and contrast agents for magnetic resonance imaging

Area of Science:

• Biomedical Imaging
• Nanotechnology
• Radiology

Background:

• Magnetic resonance imaging (MRI) is a noninvasive diagnostic tool with excellent spatial resolution.
• Current MRI contrast agents have limitations in sensitivity for small lesions and cellular activities.
• There is a need for higher efficiency contrast agents to improve diagnostic capabilities.

Purpose of the Study:

• To review the principles of MRI and advancements in contrast agent specificity.
• To explore the development of high relaxivity contrast agents.
• To discuss theranostic applications combining diagnosis and therapy.

Main Methods:

• Review of magnetic resonance imaging principles.
• Analysis of contrast agent design and synthesis.
• Exploration of theranostic agent combinations for cancer diagnosis and treatment.

Main Results:

• Gadolinium and iron oxide-based contrast agents can be synthesized for enhanced targeting.
• Specificity of contrast agents for organs like the liver and tumors is being improved.
• Theranostic approaches integrate imaging with drug delivery, thermal therapy, photodynamic therapy, and neutron capture therapy.

Conclusions:

• Advanced contrast agents improve MRI sensitivity and specificity.
• Theranostic agents offer a powerful approach for integrated cancer diagnosis and treatment.